WO2005097186A3 - Endoprotheses vasculaires bioactives conçues pour le diabete type ii et leurs procedes d'utilisation - Google Patents
Endoprotheses vasculaires bioactives conçues pour le diabete type ii et leurs procedes d'utilisation Download PDFInfo
- Publication number
- WO2005097186A3 WO2005097186A3 PCT/US2005/011231 US2005011231W WO2005097186A3 WO 2005097186 A3 WO2005097186 A3 WO 2005097186A3 US 2005011231 W US2005011231 W US 2005011231W WO 2005097186 A3 WO2005097186 A3 WO 2005097186A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diabetics
- type
- vascular
- bioligand
- pecs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/114—Nitric oxide, i.e. NO
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L2300/256—Antibodies, e.g. immunoglobulins, vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05767563A EP1737379A4 (fr) | 2004-04-05 | 2005-04-04 | Endoprotheses vasculaires bioactives concues pour le diabete type ii et leurs procedes d'utilisation |
CN200580015085XA CN1984620B (zh) | 2004-04-05 | 2005-04-04 | 用于ⅱ型糖尿病患者的生物活性支架 |
JP2007507391A JP2007532185A (ja) | 2004-04-05 | 2005-04-04 | Ii型糖尿病のための生理活性ステントおよびその使用方法 |
AU2005231458A AU2005231458A1 (en) | 2004-04-05 | 2005-04-04 | Bioactive stents for type II diabetics and methods for use thereof |
CA002562018A CA2562018A1 (fr) | 2004-04-05 | 2005-04-04 | Endoprotheses vasculaires bioactives concues pour le diabete type ii et leurs procedes d'utilisation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55993704P | 2004-04-05 | 2004-04-05 | |
US60/559,937 | 2004-04-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005097186A2 WO2005097186A2 (fr) | 2005-10-20 |
WO2005097186A3 true WO2005097186A3 (fr) | 2006-09-14 |
Family
ID=35125623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/011231 WO2005097186A2 (fr) | 2004-04-05 | 2005-04-04 | Endoprotheses vasculaires bioactives conçues pour le diabete type ii et leurs procedes d'utilisation |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1737379A4 (fr) |
JP (1) | JP2007532185A (fr) |
CN (1) | CN1984620B (fr) |
AU (1) | AU2005231458A1 (fr) |
CA (1) | CA2562018A1 (fr) |
WO (1) | WO2005097186A2 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8652504B2 (en) | 2005-09-22 | 2014-02-18 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
US9102830B2 (en) | 2005-09-22 | 2015-08-11 | Medivas, Llc | Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use |
US9517203B2 (en) | 2000-08-30 | 2016-12-13 | Mediv As, Llc | Polymer particle delivery compositions and methods of use |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160287708A9 (en) * | 2000-03-15 | 2016-10-06 | Orbusneich Medical, Inc. | Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device |
US20060271168A1 (en) * | 2002-10-30 | 2006-11-30 | Klaus Kleine | Degradable medical device |
EP1699527A1 (fr) | 2004-01-02 | 2006-09-13 | Advanced Cardiovascular Systems, Inc. | Dispositifs medicaux revetus de lipoproteine a haute densite |
US8163269B2 (en) * | 2004-04-05 | 2012-04-24 | Carpenter Kenneth W | Bioactive stents for type II diabetics and methods for use thereof |
WO2007067744A2 (fr) * | 2005-12-07 | 2007-06-14 | Medivas, Llc | Procédé destiné à assembler une composition d'administration polymère-agent biologique |
EP2021141A4 (fr) * | 2006-05-09 | 2013-07-03 | Medivas Llc | Polymères hydrosolubles biodégradables |
US7572625B2 (en) * | 2006-05-18 | 2009-08-11 | Boston Scientific Scimed, Inc. | Medical devices coated with drug carrier macromolecules |
WO2008086490A2 (fr) * | 2007-01-11 | 2008-07-17 | Robert Lamar Bjork, Jr | Endoprothèse coronaire à élution de médicaments multiples pour intervention coronarienne percutanée |
JP2010533548A (ja) * | 2007-07-17 | 2010-10-28 | メディバス エルエルシー | 生体吸収性エラストマー動脈支持装置および使用方法 |
US20090074831A1 (en) * | 2007-09-18 | 2009-03-19 | Robert Falotico | LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR STIMULATORS |
DE102008027095A1 (de) * | 2008-06-06 | 2009-12-17 | Siemens Aktiengesellschaft | Interventionsvorrichtung zur Sammlung von biologischem Material und Verfahren zu ihrer Herstellung |
CN101879102B (zh) * | 2009-05-07 | 2014-07-09 | 上海微创医疗器械(集团)有限公司 | 一种凹槽携载式涂层可降解型药物洗脱支架 |
EP2488225A1 (fr) * | 2009-10-16 | 2012-08-22 | DSM IP Assets B.V. | Revêtements comprenant du polyesteramide contenant des motifs bis(alpha-aminodiesters de diols) |
US9873765B2 (en) | 2011-06-23 | 2018-01-23 | Dsm Ip Assets, B.V. | Biodegradable polyesteramide copolymers for drug delivery |
US9963549B2 (en) | 2011-06-23 | 2018-05-08 | Dsm Ip Assets, B.V. | Biodegradable polyesteramide copolymers for drug delivery |
US20140220017A1 (en) | 2011-09-23 | 2014-08-07 | Universitat Stuttgart | Serum half-life extension using igbd |
US9220759B2 (en) | 2012-02-23 | 2015-12-29 | Abbott Cardiovascular Systems Inc. | Treatment of diabetic patients with a drug eluting stent and adjunctive therapy |
US9220584B2 (en) | 2012-03-30 | 2015-12-29 | Abbott Cardiovascular Systems Inc. | Treatment of diabetic patients with a stent and locally administered adjunctive therapy |
CA2892523A1 (fr) * | 2012-12-20 | 2014-06-26 | George Mihov | Revetement comprenant des copolymeres de polyesteramide pour l'administration de medicament |
EP3233067B1 (fr) | 2014-12-18 | 2019-11-06 | DSM IP Assets B.V. | Système d'administration de médicament pour délivrer des médicaments sensibles à l'acide |
EP4069327A1 (fr) * | 2019-12-04 | 2022-10-12 | Cortronik GmbH | Fibres hybrides polymères gonflables pour un manchon d'une endoprothèse intraluminale |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020106369A1 (en) * | 2000-03-17 | 2002-08-08 | Millennium Pharmaceuticals, Inc. | Method of inhibiting stenosis and restenosis |
US20030064053A1 (en) * | 2001-08-31 | 2003-04-03 | Shengjiang Liu | Multivalent protein conjugate with multiple ligand-binding domains of receptors |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0983095B1 (fr) * | 1997-05-22 | 2004-09-29 | Biomet Deutschland GmbH | Implants recouverts de peptides et procede permettant de les preparer |
US7052711B2 (en) * | 1999-09-02 | 2006-05-30 | Rice University | Nitric oxide-producing hydrogel materials |
US6379383B1 (en) * | 1999-11-19 | 2002-04-30 | Advanced Bio Prosthetic Surfaces, Ltd. | Endoluminal device exhibiting improved endothelialization and method of manufacture thereof |
US20030229393A1 (en) * | 2001-03-15 | 2003-12-11 | Kutryk Michael J. B. | Medical device with coating that promotes cell adherence and differentiation |
JP2001276210A (ja) * | 2000-03-28 | 2001-10-09 | Unitika Ltd | 抗菌性医療用具及びその製造方法 |
GB0103668D0 (en) * | 2001-02-15 | 2001-03-28 | Biointeractions Ltd | Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
WO2002065947A2 (fr) * | 2001-02-16 | 2002-08-29 | Abbott Laboratories Vascular Enterprises Limited | Implants avec fk506 |
CN1303947C (zh) * | 2001-12-13 | 2007-03-14 | 华东理工大学 | 药物洗脱性心血管支架及其制备方法 |
IL162803A0 (en) * | 2002-02-06 | 2005-11-20 | Orbus Medical Technologies Inc | Medical device with coating that promotes endothelial cell adherence and differentiation |
JP2003320036A (ja) * | 2002-05-01 | 2003-11-11 | Terumo Corp | ステント |
JP2006520217A (ja) * | 2003-02-26 | 2006-09-07 | メディバス エルエルシー | 生物活性ステントおよびその使用方法 |
DE602004024053D1 (de) * | 2003-05-07 | 2009-12-24 | Advanced Bio Prothestic Surfac | Metallische implantierbare prothesen und herstellungsverfahren dafür |
JP2009513556A (ja) * | 2003-07-17 | 2009-04-02 | バイエリッシェ ユリウス−マクシミリアンズ−ウニヴァージタット ヴュルツブルグ | 狭窄および再狭窄を阻害するための医薬品の製造におけるfak関連非キナーゼの使用 |
-
2005
- 2005-04-04 WO PCT/US2005/011231 patent/WO2005097186A2/fr active Application Filing
- 2005-04-04 CA CA002562018A patent/CA2562018A1/fr not_active Abandoned
- 2005-04-04 CN CN200580015085XA patent/CN1984620B/zh not_active Expired - Fee Related
- 2005-04-04 JP JP2007507391A patent/JP2007532185A/ja active Pending
- 2005-04-04 EP EP05767563A patent/EP1737379A4/fr not_active Withdrawn
- 2005-04-04 AU AU2005231458A patent/AU2005231458A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020106369A1 (en) * | 2000-03-17 | 2002-08-08 | Millennium Pharmaceuticals, Inc. | Method of inhibiting stenosis and restenosis |
US20030064053A1 (en) * | 2001-08-31 | 2003-04-03 | Shengjiang Liu | Multivalent protein conjugate with multiple ligand-binding domains of receptors |
Non-Patent Citations (1)
Title |
---|
See also references of EP1737379A4 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9517203B2 (en) | 2000-08-30 | 2016-12-13 | Mediv As, Llc | Polymer particle delivery compositions and methods of use |
US8652504B2 (en) | 2005-09-22 | 2014-02-18 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
US9102830B2 (en) | 2005-09-22 | 2015-08-11 | Medivas, Llc | Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use |
Also Published As
Publication number | Publication date |
---|---|
CN1984620B (zh) | 2011-03-30 |
WO2005097186A2 (fr) | 2005-10-20 |
JP2007532185A (ja) | 2007-11-15 |
CA2562018A1 (fr) | 2005-10-20 |
EP1737379A4 (fr) | 2011-08-17 |
CN1984620A (zh) | 2007-06-20 |
AU2005231458A1 (en) | 2005-10-20 |
EP1737379A2 (fr) | 2007-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005097186A3 (fr) | Endoprotheses vasculaires bioactives conçues pour le diabete type ii et leurs procedes d'utilisation | |
WO2005034852A3 (fr) | Biomateriaux et biocoacervats proteiniques, leurs procedes de fabrication et d'utilisation | |
Otsuka et al. | Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model | |
Farb et al. | Pathology of acute and chronic coronary stenting in humans | |
RU2400256C2 (ru) | Захват эндотелиальных клеток-предшественников элюирующим лекарственные средства имплантируемым медицинским устройством | |
WO2007070790A3 (fr) | Stents a auto-detection, stents a base de materiaux intelligents, systemes d'administration de medicaments, autres dispositifs medicaux et utilisations medicales de materiaux piezoelectriques materials | |
WO2007092464A3 (fr) | Procedes et dispositifs pour la reparation de la coiffe des rotateurs | |
WO2010057177A3 (fr) | Systèmes de greffe de vaisseaux à biocoacervats et biomatériaux protéiques et procédés pour leur fabrication et leur utilisation | |
WO2007030512A3 (fr) | Greffon de diffusion de medicaments | |
DK1626714T3 (da) | Dirarylurinstoffer mod sygdomme medieret af PDGFR | |
WO2006047378A3 (fr) | Compositions polymeres biocompatibles et hemocompatibles | |
Iijima et al. | Bioactive coating of decellularized vascular grafts with a temperature‐sensitive VEGF‐conjugated hydrogel accelerates autologous endothelialization in vivo | |
WO2004075781A3 (fr) | Endoprotheses vasculaires bioactives et leur mode d'emploi | |
WO2006138047A3 (fr) | Systemes de pose et de guidage de stents | |
WO2008098252A3 (fr) | Implants vasculaires et procédés de fabrication desdits implants | |
CA2467797A1 (fr) | Biocompatibilite amelioree de dispositifs medicaux implantables | |
AU2002231175A1 (en) | Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart | |
WO2006029364A3 (fr) | Dispositif d'administration in vivo d'agents bioactifs et son procede de fabrication | |
KR20080108693A (ko) | 코끝 성형술을 용이하게 하는 비연골기둥보조장치 | |
ATE529074T1 (de) | Gegabelte medizinprodukt-abgabevorrichtung | |
EP1785108A3 (fr) | Systeme de deploiement pour un dispositif medical intraluminal | |
WO2011096402A1 (fr) | Dispositif biocompatible | |
WO2011071766A3 (fr) | Greffes bioactives et composites | |
Fu et al. | Combination of calcium sulfate and simvastatin-controlled release microspheres enhances bone repair in critical-sized rat calvarial bone defects | |
Gostev et al. | Electrospun polyurethane-based vascular grafts: Physicochemical properties and functioning in vivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005231458 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2562018 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007507391 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 6024/DELNP/2006 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2005231458 Country of ref document: AU Date of ref document: 20050404 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005231458 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005767563 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580015085.X Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2005767563 Country of ref document: EP |